Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.
Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories.
Allergan is an industry leader in Open Science, a model of research and development, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. With this approach, Allergan has built one of the broadest development pipelines in the pharmaceutical industry.
For more information, visit Allergan's website at www.Allergan.com.
Sientra is a medical aesthetics company that has developed a broad portfolio of products with technologically differentiated characteristics. The Company offers breast implants, breast tissue expanders as well as BIOCORNEUM®, (scar management), and miraDry (FDA cleared device to reduce underarm sweat, odor and permanently reduce hair of all colors).
For more information, visit Sientra's website at www.Sientra.com.
Mitaka USA focuses on developing new technologies in the fields of microscopic, fluorescent, and 3D surgical imaging.
PolarityTE is a commercial-stage biotechnology and regenerative biomaterials company focused on designing and developing regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences.